Dr Peter H Lin, MD - Medicare Vascular Surgery in Arcadia, CA

Dr Peter H Lin, MD is a medicare enrolled "Surgery - Vascular Surgery" physician in Arcadia, California. He went to Chicago College Of Medicine And Surgery and graduated in 1992 and has 32 years of diverse experience with area of expertise as Vascular Surgery. He is a member of the group practice Vascular Care Specialists Of Los Angeles and his current practice location is 488 E Santa Clara St Ste 303, Arcadia, California. You can reach out to his office (for appointments etc.) via phone at (626) 275-9566.

Dr Peter H Lin is licensed to practice in California (license number G135687) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1982784625.

Contact Information

Dr Peter H Lin, MD
488 E Santa Clara St Ste 303,
Arcadia, CA 91006-7231
(626) 275-9566
(626) 387-4188



Physician's Profile

Full NameDr Peter H Lin
GenderMale
SpecialityVascular Surgery
Experience32 Years
Location488 E Santa Clara St Ste 303, Arcadia, California
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Peter H Lin attended and graduated from Chicago College Of Medicine And Surgery in 1992
  NPI Data:
  • NPI Number: 1982784625
  • Provider Enumeration Date: 10/17/2006
  • Last Update Date: 11/02/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 0143248872
  • Enrollment ID: I20150615001601

Medical Identifiers

Medical identifiers for Dr Peter H Lin such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1982784625NPI-NPPES
1982784625OtherCAMEDI-CAL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2086S0129XSurgery - Vascular Surgery L5810 (Texas)Secondary
2086S0129XSurgery - Vascular Surgery G135687 (California)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Methodist Hospital Of Southern CaArcadia, CAHospital
San Gabriel Valley Medical CenterSan gabriel, CAHospital
Garfield Medical CenterMonterey park, CAHospital
Alhambra Hospital Medical CenterAlhambra, CAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Vascular Care Specialists Of Los Angeles56981834402

News Archive

Statins offer great potential as anti-aging therapy

Not only do statins extend lives by lowering cholesterol levels and reducing the risks of cardiovascular disease, but new research in the September 2013 issue of The FASEB Journal suggests that they may extend lifespans as well. Specifically, statins may reduce the rate at which telomeres shorten, a key factor in the natural aging process. This opens the door for using statins, or derivatives of statins, as an anti-aging therapy.

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Australia-PNG partnership wins major research grant to investigate tuberculosis in children

An Australia-Papua New Guinea research partnership that aims to develop a new diagnostic tool to quickly and accurately identify children with tuberculosis has been awarded a sought-after funding grant at the recent International AIDS Conference in Mexico City.

Study demonstrates potential of new approach for sorting out BRCA1 gene variants

Patients seeking certainty in genetic tests often receive a perplexing result. Many learn they carry a 'variant of unknown significance' of a disease-linked gene. Such variants might - or equally might not - increase disease risk.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Peter H Lin allows following entities to bill medicare on his behalf.
Entity NameArt Vascular & Interventional Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407353675
PECOS PAC ID: 0446506158
Enrollment ID: O20180711002270

News Archive

Statins offer great potential as anti-aging therapy

Not only do statins extend lives by lowering cholesterol levels and reducing the risks of cardiovascular disease, but new research in the September 2013 issue of The FASEB Journal suggests that they may extend lifespans as well. Specifically, statins may reduce the rate at which telomeres shorten, a key factor in the natural aging process. This opens the door for using statins, or derivatives of statins, as an anti-aging therapy.

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Australia-PNG partnership wins major research grant to investigate tuberculosis in children

An Australia-Papua New Guinea research partnership that aims to develop a new diagnostic tool to quickly and accurately identify children with tuberculosis has been awarded a sought-after funding grant at the recent International AIDS Conference in Mexico City.

Study demonstrates potential of new approach for sorting out BRCA1 gene variants

Patients seeking certainty in genetic tests often receive a perplexing result. Many learn they carry a 'variant of unknown significance' of a disease-linked gene. Such variants might - or equally might not - increase disease risk.

Read more Medical News

› Verified 4 days ago

Entity NameVascular Care Specialists Of Los Angeles
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972181493
PECOS PAC ID: 5698183440
Enrollment ID: O20210416000978

News Archive

Statins offer great potential as anti-aging therapy

Not only do statins extend lives by lowering cholesterol levels and reducing the risks of cardiovascular disease, but new research in the September 2013 issue of The FASEB Journal suggests that they may extend lifespans as well. Specifically, statins may reduce the rate at which telomeres shorten, a key factor in the natural aging process. This opens the door for using statins, or derivatives of statins, as an anti-aging therapy.

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Australia-PNG partnership wins major research grant to investigate tuberculosis in children

An Australia-Papua New Guinea research partnership that aims to develop a new diagnostic tool to quickly and accurately identify children with tuberculosis has been awarded a sought-after funding grant at the recent International AIDS Conference in Mexico City.

Study demonstrates potential of new approach for sorting out BRCA1 gene variants

Patients seeking certainty in genetic tests often receive a perplexing result. Many learn they carry a 'variant of unknown significance' of a disease-linked gene. Such variants might - or equally might not - increase disease risk.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Peter H Lin is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Peter H Lin, MD
488 E Santa Clara St Ste 303,
Arcadia, CA 91006-7231

Ph: (626) 275-9566
Dr Peter H Lin, MD
488 E Santa Clara St Ste 303,
Arcadia, CA 91006-7231

Ph: (626) 275-9566

News Archive

Statins offer great potential as anti-aging therapy

Not only do statins extend lives by lowering cholesterol levels and reducing the risks of cardiovascular disease, but new research in the September 2013 issue of The FASEB Journal suggests that they may extend lifespans as well. Specifically, statins may reduce the rate at which telomeres shorten, a key factor in the natural aging process. This opens the door for using statins, or derivatives of statins, as an anti-aging therapy.

3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive licensing deal with PharmAbcine Inc. for the development, manufacturing and marketing of DIG-KT, a bi-specific monoclonal antibody ("mAb") targeting both VEGFR2/KDR and Tie-2 pathways for cancer in the territory of Greater China (including mainland China, Taiwan, Hong Kong and Macau) and Korea.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Australia-PNG partnership wins major research grant to investigate tuberculosis in children

An Australia-Papua New Guinea research partnership that aims to develop a new diagnostic tool to quickly and accurately identify children with tuberculosis has been awarded a sought-after funding grant at the recent International AIDS Conference in Mexico City.

Study demonstrates potential of new approach for sorting out BRCA1 gene variants

Patients seeking certainty in genetic tests often receive a perplexing result. Many learn they carry a 'variant of unknown significance' of a disease-linked gene. Such variants might - or equally might not - increase disease risk.

Read more News

› Verified 4 days ago


Surgery Doctors in Arcadia, CA

Bala S Chandrasekhar, MD
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 255 E. Santa Clara St., Suite 310, Arcadia, CA 91006
Phone: 626-447-1092    Fax: 626-447-4125
Robert H Papadopoulos, M.D.
Surgery
Medicare: Medicare Enrolled
Practice Location: 612 W Duarte Rd, Suite 602, Arcadia, CA 91007
Phone: 626-446-4645    Fax: 626-446-1626
Bengt Florian Pehrsson, MD
Surgery
Medicare: Medicare Enrolled
Practice Location: 622 W Duarte Rd, #301, Arcadia, CA 91007
Phone: 626-445-0600    Fax: 626-574-8654
Dr. Ramon Oceguera, M.D.
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 622 W Duarte Rd Ste 104, Arcadia, CA 91007
Phone: 626-445-2974    Fax: 626-445-0093
Troy Lamar, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 51 N Fifth Avenue, Suite 202, Arcadia, CA 91006
Phone: 626-445-0600    Fax: 626-574-8654
Dr. Julius Wah Gee, DO
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 1032 Leandra Lane, Arcadia, CA 91006
Phone: 626-230-6582    
William W. Tseng, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 301 W Huntington Dr Ste 400, Arcadia, CA 91007
Phone: 626-218-9840    Fax: 626-218-9860

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.